COMPOUNDS FOR USE IN TREATING NEUROMUSCULAR DISORDERS - European Patent Office - EP 3307262 B1
Claus Oleson - BioLeader Interview - PIR International
Founders — NMD Pharma
Christina Grønberg – University of Copenhagen
Invitation to invest in Initiator Pharma A/S
Foundations invest DKK 280 million in biomedical company
Soonicorn Club: Top Tech Startups In Denmark To Watch Out For | Tracxn
Initiator Pharma
NMD Pharma A/S | LinkedIn
NMD Pharma A/S | LinkedIn
Aarhus-biotek tager kampen op mod neuromuskulære sygdomme - Business Review
Saniona participates in formation of Initiator Pharma A/S and spins out three noncore Saniona programs
Claus Olesen – Co-Founder/CEO – Stipe Therapeutics | LinkedIn
Initiator Pharma
Claus Oleson - BioLeader Interview - PIR International
Initiator Pharma | LinkedIn
Claus Elsborg Olesen - Ownr.dk
Novo A/S Novo Seeds. Letter from the CEO SYNLAB. Novo Ventures - PDF Free Download
Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person Profile
Founders — NMD Pharma
Initiator Pharma A/S - Stock and Shares News | IPO HUB
UNIVERSITY OF COPENHAGEN Project title Development of novel treatments against myotonia Mentor 1 Pontus Gourdon, MS
Aarhus Biotech Company takes up the fight against neuromuscular diseases</a> — NMD Pharma
Initiator Pharma
Claus Olesen – Co-Founder/CEO – Stipe Therapeutics | LinkedIn
